European Journal of Molecular & Clinical Medicine

Abstract

Abstract
Nowadays, in the absence of a common doctrine and conceptual schemes, both of
treatment and prevention of atopic diseases, we have practically uncontrolled growth of
this pathology. This dead-end situation can only be changed, if there are clinical atopy
biomarkers, thus making preventive therapy possible. The article presents the program
development and implementation results for primary prevention of atopic dermatitis
based on identified biomarkers. A preventive treatment method, based on the correction 
of intestinal microbiota through selective decontamination of opportunistic microflora
using bacteriophages has been substantiated. The results of ten-year experience in
secondary and primary prevention of atopic diseases are presented